Searchable abstracts of presentations at key conferences in endocrinology

ea0050p203 | Diabetes and Cardiovascular | SFEBES2017

Induced maturity affects normal beta cell function

Nasteska Daniela , Fine Nicholas HF , Rutter Guy A , Zhou Qiao , Hodson David J

Aim: One of the hallmarks of type 2 diabetes (T2D) is impaired beta cell function, which develops in part as a result of widespread cellular de-differentiation. The current state-of-the-art defines beta cells as a heterogeneous islet population, with the existence of individual subpopulations including specialised ‘pacemakers’. We sought here to understand how overexpression-induced beta cell maturity affects such heterogeneity, befo...

ea0050p203 | Diabetes and Cardiovascular | SFEBES2017

Induced maturity affects normal beta cell function

Nasteska Daniela , Fine Nicholas HF , Rutter Guy A , Zhou Qiao , Hodson David J

Aim: One of the hallmarks of type 2 diabetes (T2D) is impaired beta cell function, which develops in part as a result of widespread cellular de-differentiation. The current state-of-the-art defines beta cells as a heterogeneous islet population, with the existence of individual subpopulations including specialised ‘pacemakers’. We sought here to understand how overexpression-induced beta cell maturity affects such heterogeneity, befo...

ea0065oc1.5 | Metabolism and Obesity | SFEBES2019

Prolyl-hydroxylase 3 maintains β-cell glucose-sensing under metabolic stress

Cuozzo Federica , Nasteska Daniela , Thakker Alpesh , Westbrook Rebecca , Bakar Rula Bany , Cantley James , Tennant Daniel , Hodson David J

Aims: Prolyl-4 hydroxylase domain protein 3 (PHD3) is an alpha ketoglutarate-dependent dioxygenase involved in the oxygen-dependent regulation of cell phenotype. While PHD3 has been reported to suppress insulin sensitivity in the liver, little is known about effects of the enzyme in insulin-secreting β-cells.Methods: βPHD3−/− mice were generated by crossing the Ins1Cre driver line with animals bearing a floxed Egln3</...

ea0059p106 | Diabetes &amp; cardiovascular | SFEBES2018

Bright and specific far-red labels for visualizing endogenous glucagon-like peptide-1 receptors

Ast Julia , Podewin Tom , Arvaniti Anastasia , Fine Nick HF , Stamataki Zania , Broichhagen Johannes , Johnsson Kai , Hodson David J

The glucagon-like peptide-1 receptor (GLP-1R) is a G protein-coupled receptor (GPCR) expressed in various tissues such as brain and pancreas where it contributes to the regulation of energy expenditure and metabolism. Due to its involvement in glucose-dependent release of insulin from pancreatic beta cells, the GLP-1R has become a blockbuster target for the treatment of type 2 diabetes. Despite this, debate still exists about the exact distribution of the GLP-1R throughout the...

ea0065p197 | Metabolism and Obesity | SFEBES2019

Immature β-cells are required for normal islet function and insulin release

Nasteska Daniela , Fine Nicholas H F , Ashford Fiona B , Smith Gabrielle , Bakhti Mostafa , Bastidas-Ponce Aimee , Rutter Guy A , Lickert Heiko , Zhou Qiao , Akerman Ildem , Hodson David J

Background: A normal islet includes both mature and immature β-cells, with the former possessing higher insulin content and the latter displaying better proliferative capacity. However, it remains unknown whether immature β-cells also contribute to the regulation of insulin release, especially by commanding the activity of their mature counterparts.Materials and methods: Pdx1, Mafa, and Ngn3 were overexpressed in &#94...

ea0050oc1.4 | Early Career Oral Communications | SFEBES2017

An investigation into sodium-iodide symporter (NIS) dimerization and its impact on radioiodide uptake in thyroid cancer

Thompson Rebecca J. , Fletcher Alice , Nieto Hannah , Alshahrani Mohammed , Baker Katie , Mueller Jonathan W. , Fine Nicholas H.F. , Hodson David J. , Read Martin L. , Boelaert Kristien , Smith Vicki E. , McCabe Christopher J.

The ability of the thyroid to accumulate iodide via the sodium-iodide symporter (NIS) can be utilised to successfully treat the majority of thyroid cancers with radioiodide. However, approximately 25% of thyroid cancers lose this functional NIS activity and become unresponsive to radioiodide therapy, resulting in a poorer prognosis. Our knowledge of NIS regulation is limited, but as dimerisation of NIS has been proposed, we sought to investigate NIS dimerisation and its impact...

ea0050oc1.4 | Early Career Oral Communications | SFEBES2017

An investigation into sodium-iodide symporter (NIS) dimerization and its impact on radioiodide uptake in thyroid cancer

Thompson Rebecca J. , Fletcher Alice , Nieto Hannah , Alshahrani Mohammed , Baker Katie , Mueller Jonathan W. , Fine Nicholas H.F. , Hodson David J. , Read Martin L. , Boelaert Kristien , Smith Vicki E. , McCabe Christopher J.

The ability of the thyroid to accumulate iodide via the sodium-iodide symporter (NIS) can be utilised to successfully treat the majority of thyroid cancers with radioiodide. However, approximately 25% of thyroid cancers lose this functional NIS activity and become unresponsive to radioiodide therapy, resulting in a poorer prognosis. Our knowledge of NIS regulation is limited, but as dimerisation of NIS has been proposed, we sought to investigate NIS dimerisation and its impact...